CP-66713

• Description :

  CP-66713 is a selective adenosine A2 receptor antagonist, with Ki of 22 nM. CP-66713 inhibits induction of long-term potentiation of evoked synaptic potentials. CP-66713 can be used in the study of neurological diseases[1].

• UNSPSC :

  12352005

• Hazard Statement :

  H302-H315-H319-H335

• Target :

  Adenosine Receptor

• Related Pathways :

  GPCR/G Protein

• Field of Research :

  Neurological Disease

• Smiles :

  NC1=NC2=C(N3C1=NN=C3C4=CC=CC=C4)C=C(Cl)C=C2

• Molecular Formula :

  C15H10ClN5

• Molecular Weight :

  295.73

• Precautions :

  P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501

• References & Citations :

  [1]Sekino Y, et al. Adenosine (A2) antagonist inhibits induction of long-term potentiation of evoked synaptic potentials but not of the population spike in hippocampal CA1 neurons. Biochem Biophys Res Commun. 1991 Dec 31;181 (3) :1010-4.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [91896-57-0]